Trial intelligence / Profile preview

Combined citalopram and rivastigmine effects on memory in healthy volunteers

NL-OMON32707Active, not recruiting

Sponsor
Maastricht University
Start
Feb 2010
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of citalopram and rivastigmine (4 arms), sponsored by Maastricht University. Primary endpoints: Behavioral performance on verbal learning task, Behavioral performance on continuous recognition memory task and 2 more. Started Feb 2010; status: active, not recruiting.

02

Drugs

citalopramrivastigmine

Beyond the preview

Go deeper on NL-OMON32707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call